|
Volumn 176, Issue 2, 1998, Pages 176-178
|
Orally administered heparin for preventing deep venous thrombosis
a c b b a a a,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACID;
HEPARIN;
N [8 (2 HYDROXYBENZOYL)AMINO]CAPRYLATE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BLOOD CLOTTING;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG POTENTIATION;
ELECTROPHORETIC MOBILITY;
HEPARINIZATION;
INCIDENCE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MOLECULAR WEIGHT;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
RAT;
SCLEROTHERAPY;
THROMBOGENESIS;
ADMINISTRATION, ORAL;
ANIMALS;
CAPRYLATES;
DATA INTERPRETATION, STATISTICAL;
DRUG THERAPY, COMBINATION;
HEPARIN;
INJECTIONS, INTRAVENOUS;
INTESTINAL ABSORPTION;
MALE;
PARTIAL THROMBOPLASTIN TIME;
RANDOM ALLOCATION;
RATS;
RATS, SPRAGUE-DAWLEY;
STOMACH;
THROMBOPHLEBITIS;
|
EID: 17644442033
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9610(98)00127-5 Document Type: Conference Paper |
Times cited : (51)
|
References (9)
|